Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγnull mice reconstituted with human peripheral blood mononuclear cells.

Dis Model Mech · 2021 · PMC7847261 · PMID 33293281

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

just failed to be significantP =0.054so close (0.05 < p ≤ 0.1)

1 A,B, the frequencies of CD4 + CD134 + T cells were increased, but the differences just failed to be significant [non-UC, 12.11±21.27, mean±s.d.; UC, 21.54±25.71; P =0.054; 95% confidence interval (CI): −19.06 to 0.17].

also in 20 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.